Cargando…
Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey
BACKGROUND: European Society for Medical Oncology Women for Oncology (ESMO W4O) research has previously shown under-representation of female oncologists in leadership roles. As early reports suggested disproportionate effects of the COVID-19 pandemic on women, the ESMO W4O Committee initiated a stud...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233649/ https://www.ncbi.nlm.nih.gov/pubmed/34144778 http://dx.doi.org/10.1016/j.esmoop.2021.100131 |
_version_ | 1783713900748865536 |
---|---|
author | Garrido, P. Adjei, A.A. Bajpai, J. Banerjee, S. Berghoff, A.S. Choo, S.P. Felip, E. Furness, A.J.S. Garralda, E. Haanen, J. Letsch, A. Linardou, H. Peters, S. Sessa, C. Tabernero, J. Tsang, J. Yang, J.C-.H. Garassino, M.C. |
author_facet | Garrido, P. Adjei, A.A. Bajpai, J. Banerjee, S. Berghoff, A.S. Choo, S.P. Felip, E. Furness, A.J.S. Garralda, E. Haanen, J. Letsch, A. Linardou, H. Peters, S. Sessa, C. Tabernero, J. Tsang, J. Yang, J.C-.H. Garassino, M.C. |
author_sort | Garrido, P. |
collection | PubMed |
description | BACKGROUND: European Society for Medical Oncology Women for Oncology (ESMO W4O) research has previously shown under-representation of female oncologists in leadership roles. As early reports suggested disproportionate effects of the COVID-19 pandemic on women, the ESMO W4O Committee initiated a study on the impact of the pandemic on the lives of female and male oncologists. METHODS: A questionnaire was sent to ESMO members and put on the ESMO website between 8 June 2020 and 2 July 2020. Questions focused on the working (hospital tasks, laboratory tasks, science) and home (household management, childcare, parent care, personal care) lives of oncologists during and after COVID-19-related lockdowns. RESULTS: Of 649 respondents, 541 completed the questionnaire. Of these, 58% reported that COVID-19 had affected their professional career, 83% of whom said this was in a negative way (85% of women versus 76% of men). Approximately 86% reported that COVID-19 had changed their personal life and 82% their family life. Women were again significantly more affected than men: personal life (89% versus 78%; P = 0.001); family life (84% versus 77%; P = 0.037). During lockdowns, women reported increased time spent on hospital and laboratory tasks compared with men (53% versus 46% and 33% versus 26%, respectively) and a significantly higher proportion of women than men spent less time on science (39% versus 25%) and personal care (58% versus 39%). After confinement, this trend remained for science (42% versus 23%) and personal care (55% versus 36%). CONCLUSIONS: The COVID-19 pandemic has adversely affected the professional and home lives of oncologists, especially women. Reduced research time for female oncologists may have long-lasting career consequences, especially for those at key stages in their career. The gender gap for promotion to leadership positions may widen further as a result of the pandemic. |
format | Online Article Text |
id | pubmed-8233649 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-82336492021-06-29 Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey Garrido, P. Adjei, A.A. Bajpai, J. Banerjee, S. Berghoff, A.S. Choo, S.P. Felip, E. Furness, A.J.S. Garralda, E. Haanen, J. Letsch, A. Linardou, H. Peters, S. Sessa, C. Tabernero, J. Tsang, J. Yang, J.C-.H. Garassino, M.C. ESMO Open Original Research BACKGROUND: European Society for Medical Oncology Women for Oncology (ESMO W4O) research has previously shown under-representation of female oncologists in leadership roles. As early reports suggested disproportionate effects of the COVID-19 pandemic on women, the ESMO W4O Committee initiated a study on the impact of the pandemic on the lives of female and male oncologists. METHODS: A questionnaire was sent to ESMO members and put on the ESMO website between 8 June 2020 and 2 July 2020. Questions focused on the working (hospital tasks, laboratory tasks, science) and home (household management, childcare, parent care, personal care) lives of oncologists during and after COVID-19-related lockdowns. RESULTS: Of 649 respondents, 541 completed the questionnaire. Of these, 58% reported that COVID-19 had affected their professional career, 83% of whom said this was in a negative way (85% of women versus 76% of men). Approximately 86% reported that COVID-19 had changed their personal life and 82% their family life. Women were again significantly more affected than men: personal life (89% versus 78%; P = 0.001); family life (84% versus 77%; P = 0.037). During lockdowns, women reported increased time spent on hospital and laboratory tasks compared with men (53% versus 46% and 33% versus 26%, respectively) and a significantly higher proportion of women than men spent less time on science (39% versus 25%) and personal care (58% versus 39%). After confinement, this trend remained for science (42% versus 23%) and personal care (55% versus 36%). CONCLUSIONS: The COVID-19 pandemic has adversely affected the professional and home lives of oncologists, especially women. Reduced research time for female oncologists may have long-lasting career consequences, especially for those at key stages in their career. The gender gap for promotion to leadership positions may widen further as a result of the pandemic. Elsevier 2021-05-25 /pmc/articles/PMC8233649/ /pubmed/34144778 http://dx.doi.org/10.1016/j.esmoop.2021.100131 Text en © 2021 Published by Elsevier Ltd on behalf of European Society for Medical Oncology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Research Garrido, P. Adjei, A.A. Bajpai, J. Banerjee, S. Berghoff, A.S. Choo, S.P. Felip, E. Furness, A.J.S. Garralda, E. Haanen, J. Letsch, A. Linardou, H. Peters, S. Sessa, C. Tabernero, J. Tsang, J. Yang, J.C-.H. Garassino, M.C. Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey |
title | Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey |
title_full | Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey |
title_fullStr | Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey |
title_full_unstemmed | Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey |
title_short | Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey |
title_sort | has covid-19 had a greater impact on female than male oncologists? results of the esmo women for oncology (w4o) survey |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233649/ https://www.ncbi.nlm.nih.gov/pubmed/34144778 http://dx.doi.org/10.1016/j.esmoop.2021.100131 |
work_keys_str_mv | AT garridop hascovid19hadagreaterimpactonfemalethanmaleoncologistsresultsoftheesmowomenforoncologyw4osurvey AT adjeiaa hascovid19hadagreaterimpactonfemalethanmaleoncologistsresultsoftheesmowomenforoncologyw4osurvey AT bajpaij hascovid19hadagreaterimpactonfemalethanmaleoncologistsresultsoftheesmowomenforoncologyw4osurvey AT banerjees hascovid19hadagreaterimpactonfemalethanmaleoncologistsresultsoftheesmowomenforoncologyw4osurvey AT berghoffas hascovid19hadagreaterimpactonfemalethanmaleoncologistsresultsoftheesmowomenforoncologyw4osurvey AT choosp hascovid19hadagreaterimpactonfemalethanmaleoncologistsresultsoftheesmowomenforoncologyw4osurvey AT felipe hascovid19hadagreaterimpactonfemalethanmaleoncologistsresultsoftheesmowomenforoncologyw4osurvey AT furnessajs hascovid19hadagreaterimpactonfemalethanmaleoncologistsresultsoftheesmowomenforoncologyw4osurvey AT garraldae hascovid19hadagreaterimpactonfemalethanmaleoncologistsresultsoftheesmowomenforoncologyw4osurvey AT haanenj hascovid19hadagreaterimpactonfemalethanmaleoncologistsresultsoftheesmowomenforoncologyw4osurvey AT letscha hascovid19hadagreaterimpactonfemalethanmaleoncologistsresultsoftheesmowomenforoncologyw4osurvey AT linardouh hascovid19hadagreaterimpactonfemalethanmaleoncologistsresultsoftheesmowomenforoncologyw4osurvey AT peterss hascovid19hadagreaterimpactonfemalethanmaleoncologistsresultsoftheesmowomenforoncologyw4osurvey AT sessac hascovid19hadagreaterimpactonfemalethanmaleoncologistsresultsoftheesmowomenforoncologyw4osurvey AT taberneroj hascovid19hadagreaterimpactonfemalethanmaleoncologistsresultsoftheesmowomenforoncologyw4osurvey AT tsangj hascovid19hadagreaterimpactonfemalethanmaleoncologistsresultsoftheesmowomenforoncologyw4osurvey AT yangjch hascovid19hadagreaterimpactonfemalethanmaleoncologistsresultsoftheesmowomenforoncologyw4osurvey AT garassinomc hascovid19hadagreaterimpactonfemalethanmaleoncologistsresultsoftheesmowomenforoncologyw4osurvey |